Eye Care

The Pharmacy Times® Eye Care resource center provides clinical news and articles, coverage from ophthalmology conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
Brolucizumab is the most clinically advanced humanized single-chain antibody fragment. This type of antibody is highly sought after due to their small size, enhanced tissue penetration, rapid clearance from systemic circulation, and drug delivery characteristics.
[[thumbnail_alt_text]]
Alembic Pharmaceuticals has received FDA approval for Dorzolamide Hydrochloride Ophthalmic Solution USP, 2%, therapeutically equivalent to Trusopt Ophthalmic Solution, 2% (Merck Sharp & Dohme Corp.).
 
[[thumbnail_alt_text]]
Stephanie Conway, PharmD, RPh, Associate Professor at Massachusetts College of Pharmacy & Health Sciences—Worcester/Manchester, discusses best practices for encouraging collaboration between pharmacy and optometry students. 
[[thumbnail_alt_text]]
Stephanie Conway, PharmD, RPh, Associate Professor at Massachusetts College of Pharmacy & Health Sciences—Worcester, discusses the links between ophthalmic conditions, over-the-counter ophthalmic products, and pharmacists.
[[thumbnail_alt_text]]
Kaelen C. Dunican, PharmD, Professor at MCPHS University—Worcester/Manchester, MA discusses an interprofessional, educational activity with pharmacy and optometry students for reviewing common, self-treatable ophthalmic conditions.
[[thumbnail_alt_text]]
JK is experiencing gastrointestinal effects. What could be the cause?
[[thumbnail_alt_text]]
Did you know that eyedrops are color-coded for patient safety and adherence?
[[thumbnail_alt_text]]
Vector-based gene therapy shows efficacy treating glaucoma.
[[thumbnail_alt_text]]
Daily eye drops may increase medication nonadherence in patients with glaucoma.
[[thumbnail_alt_text]]
Stem cell exosomes observed to protect retinal cells in a recent study.
[[thumbnail_alt_text]]
Observing retinal changes and treating patients with an anti-diabetic drug could protect against Parkinson’s disease progression.
 
[[thumbnail_alt_text]]
Patients who received their prescriptions by mail were the least likely to be adherent.